Moreover, inhibiting PI3K/AKT/mTOR can promote the secretion of immunosuppressive cytokines (109) and infiltration of myeloid-derived suppressor cells (MDSCs) (110), which would enhance the anti-tumor immune response. The gene discussed is MTOR; the disease is neoplasm.